Verve Therapeutics
VERV
trading on NASDAQ
since 2021
$11.00
(Δ 77.92%)
+$4.80 since open
Verve Therapeutics is a biotechnology company focused on developing innovative gene-editing therapies to treat serious and life-threatening diseases such as cardiovascular and metabolic disorders.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $6.25 | $6.41 | $5.94 | $543.77M | 3.01M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.35 | n/a | 29.62 | -111.10% | -94.11% | 0% |